Safranal-loaded gold nanoparticles alleviate hepatocellular carcinoma via targeting the Wnt/β-catenin pathway. [PDF]
Samra YA+3 more
europepmc +1 more source
Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions
Alzheimer's disease treatment is evolving rapidly, with emerging strategies targeting multiple disease pathways. This graphical abstract highlights the shift from traditional therapies to innovative approaches that hold promise for improving outcomes.
Tapas Kumar Mohapatra+4 more
wiley +1 more source
USP37 prevents unscheduled replisome unloading through MCM complex deubiquitination. [PDF]
Bolhuis DL+7 more
europepmc +1 more source
Targeting the Menin–KMT2A interaction in leukemia: Lessons learned and future directions
Abstract Chromosomal rearrangements involving the Mixed Lineage Leukemia gene (MLL1, KMT2A) are defining a genetically distinct subset in about 10% of human acute leukemias. Translocations involving the KMT2A‐locus at chromosome 11q23 are resulting in the formation of a chimeric oncogene, where the N‐terminal part of KMT2A is fused to a variety of ...
Florian Perner+3 more
wiley +1 more source
Targeting the DNA damage response through TBL1X in mantle cell lymphoma. [PDF]
Pray B+18 more
europepmc +1 more source
Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase [PDF]
Cascales, H.S.+4 more
core +3 more sources
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner+7 more
wiley +1 more source
CDC6 Inhibits CDK1 Activity in MII-Arrested Oocyte Cell-Free Extract. [PDF]
Dillac L+5 more
europepmc +1 more source
What's New? Currently, no published data on homologous recombination deficiency (HRD) testing in the setting of molecular tumor boards exist. This study in a cohort of 237 patients encompassing 24 different tumor entities assessed by a molecular tumor board shows that inactivating alterations of BRCA1/2 are not always associated with an elevated ...
Christoph Schubart+26 more
wiley +1 more source
Simultaneous cyclin D1 overexpression and p27<sup>kip1</sup> knockdown enable robust Müller glia cell cycle reactivation in uninjured mouse retina. [PDF]
Wu Z+6 more
europepmc +1 more source